Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Psoriatic disease and tuberculosis nowadays.

Balato N, Di Costanzo L, Ayala F, Balato A, Sanduzzi A, Bocchino M.

Clin Dev Immunol. 2012;2012:747204. doi: 10.1155/2012/747204. Epub 2012 May 8. Review.

PMID:
22645622
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.

Doherty SD, Van Voorhees A, Lebwohl MG, Korman NJ, Young MS, Hsu S, National Psoriasis Foundation.

J Am Acad Dermatol. 2008 Aug;59(2):209-17. doi: 10.1016/j.jaad.2008.03.023. Epub 2008 May 15.

PMID:
18485527
[PubMed - indexed for MEDLINE]
3.

High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer.

Bordignon V, Bultrini S, Prignano G, Sperduti I, Piperno G, Bonifati C, Filippetti M, Toma L, Latini A, Di Cecio M, Giuliani A, Vocaturo A, Trento E, D' Agosto G, Francesconi F, Cataldo A, Vento A, Cilenti V, Berardesca E, Ameglio F, Cordiali Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):213-20.

PMID:
21880210
[PubMed - indexed for MEDLINE]
4.

[Infectious risk].

Calabuig E, Salavert M.

Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:14-22. Spanish.

PMID:
19080987
[PubMed - indexed for MEDLINE]
5.

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Tobin AM, Kirby B.

BioDrugs. 2005;19(1):47-57. Review.

PMID:
15691217
[PubMed - indexed for MEDLINE]
6.

Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.

Sánchez-Moya AI, Dauden E.

J Eur Acad Dermatol Venereol. 2011 Jun;25(6):730-3. doi: 10.1111/j.1468-3083.2010.03836.x. Epub 2010 Sep 14.

PMID:
21564322
[PubMed - indexed for MEDLINE]
7.

Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines.

Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, Doria A.

Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S72-8. Review.

PMID:
16466629
[PubMed - indexed for MEDLINE]
8.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
[PubMed - indexed for MEDLINE]
9.

Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?

Shear NH.

Drug Saf. 2006;29(1):49-66. Review.

PMID:
16454534
[PubMed - indexed for MEDLINE]
10.

The concept of psoriasis as a systemic inflammation: implications for disease management.

Reich K.

J Eur Acad Dermatol Venereol. 2012 Mar;26 Suppl 2:3-11. doi: 10.1111/j.1468-3083.2011.04410.x. Review.

PMID:
22356630
[PubMed - indexed for MEDLINE]
11.

[How I treat....psoriasis comorbidities by adalimumab (Humira) anti-TNFalpha].

Piérard-Franchimont C, Henry F, Szepetiuk G, Piérard GE.

Rev Med Liege. 2010 Oct;65(10):545-8. French.

PMID:
21128358
[PubMed - indexed for MEDLINE]
12.

Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.

Channual J, Wu JJ, Dann FJ.

Dermatol Ther. 2009 Jan-Feb;22(1):61-73. doi: 10.1111/j.1529-8019.2008.01217.x. Review.

PMID:
19222518
[PubMed - indexed for MEDLINE]
13.

Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.

Chiu HY, Hsueh PR, Tsai TF.

Br J Dermatol. 2011 Mar;164(3):553-9. doi: 10.1111/j.1365-2133.2010.10137.x. Epub 2011 Feb 17.

PMID:
21083541
[PubMed - indexed for MEDLINE]
14.

Transient improvement in chronic psoriasis after treatment of TNF-α blocker induced disseminated M. tuberculosis infection.

Letada PR, Hitchcock E, Steele SL, Winstanley D.

J Drugs Dermatol. 2012 Jan;11(1):119-20.

PMID:
22206087
[PubMed - indexed for MEDLINE]
15.

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.

Sfikakis PP.

Curr Dir Autoimmun. 2010;11:180-210. doi: 10.1159/000289205. Epub 2010 Feb 18. Review.

PMID:
20173395
[PubMed - indexed for MEDLINE]
16.

The psoriatic patient profile for infliximab.

Gisondi P, Malara G, Ardigò M.

Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1445-51.

PMID:
22288305
[PubMed - indexed for MEDLINE]
17.

Long-term prognosis in patients with psoriasis.

Gulliver W.

Br J Dermatol. 2008 Aug;159 Suppl 2:2-9. doi: 10.1111/j.1365-2133.2008.08779.x. Review.

PMID:
18700909
[PubMed - indexed for MEDLINE]
18.

The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.

Piérard GE, Piérard-Franchimont C, Szepetiuk G, Paquet P, Quatresooz P.

Expert Opin Biol Ther. 2010 Aug;10(8):1197-208. doi: 10.1517/14712598.2010.500283. Review.

PMID:
20560729
[PubMed - indexed for MEDLINE]
19.

Tumour necrosis factor alpha inhibitors: screening for tuberculosis infection in inflammatory bowel disease.

Gupta A, Street AC, Macrae FA.

Med J Aust. 2008 Feb 4;188(3):168-70.

PMID:
18241178
[PubMed - indexed for MEDLINE]
20.

[Recommendations for tuberculosis screening before and during treatment with tumour necrosis factor inhibitors].

Mandić D, Curcić R, Radosavljević G, Damjanov N, Stefanović D, Mitić I, Dimić A.

Srp Arh Celok Lek. 2009 Mar-Apr;137(3-4):211-6. Serbian.

PMID:
19459572
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk